Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?

Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?

Agnieszka Wesołek-Leszczyńska,1,2 Katarzyna Pastusiak,1 Paweł Bogdański,1,* Monika Szulińska1,* 1Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Pozna&nac...

ver descrição completa

Detalhes bibliográficos
Principais autores: Wesołek-Leszczyńska A, Pastusiak K, Bogdański P, Szulińska M
Formato: Artigo
Idioma:English
Publicado em: Dove Medical Press 2024-04-01
coleção:Diabetes, Metabolic Syndrome and Obesity
Assuntos:
fat tissue
metabolic syndrome
adipokines
adipocytes
obesity
Acesso em linha:https://www.dovepress.com/can-adipokine-fam19a5-be-a-biomarker-of-metabolic-disorders-peer-reviewed-fulltext-article-DMSO

Internet

https://www.dovepress.com/can-adipokine-fam19a5-be-a-biomarker-of-metabolic-disorders-peer-reviewed-fulltext-article-DMSO

Registros relacionados